Nexus Pharmaceuticals is releasing methylene blue injection. Methylene blue injection is indicated for the treatment of methemoglobinemia—a condition that affects the blood’s ability to carry oxygen. ...

Mumbai: Glenmark Pharmaceuticals Inc., USA has announced the launch of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) ...

Methylene blue injection 50 mg/10ml is an oxidation-reduction agent indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia. “Methylene Blue Injection USP is the ...

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals, LLC announces the U.S. Food and Drug Administration (FDA) approval of Methylene Blue Injection, USP. Methylene Blue is an ...

Glenmark Pharmaceuticals, USA has launched a generic Methylene Blue Injection USP targeting a $19 million market in the US.

Glenmark Pharmaceuticals said its subsidiary, Glenmark Pharmaceuticals Inc., USA, has launched Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) in single-dose vial form.

Glenmark Pharmaceuticals Inc., USA (Glenmark) today announced the launch of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single Dose Vial.

This study investigated the effect of fiberoptic ductoscopy (FDS) combined with methylene blue staining immediately after FDS procedure on pathological nipple discharge diseases. A retrospective ...

A vibrantly-hued dye known as methylene blue has a long history of medical uses. And recently, it's getting rave reviews on social media for its reported anti-aging effects and ability to boost energy ...

Glenmark Pharmaceuticals Inc., USA announced the launch of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial. Glenmark’s Methylene Blue Injection USP is bioequivalent and ...